Background
==========

Cough is one of the most bothersome symptoms of illness, and is the most common cause of outpatient acute care visits in the United States each year \[[@B1]\]. The causes of cough are varied and multi-factorial, ranging from simple upper respiratory infections to pneumonia to chronic conditions such as asthma and emphysema. Despite the extremely common nature of this symptom and its variability based on etiology, cough is typically assessed only subjectively in clinical and research settings. Even the most expensive clinical trials related to diseases such as asthma assess cough subjectively with diary cards where patients report cough frequency and severity \[[@B2]\]. This is concerning since subjective reporting of cough has been shown to be unreliable and inconsistently accurate particularly for nighttime symptoms and for the reporting of symptoms in children \[[@B3]-[@B12]\].

As such, we developed a self-contained, ambulatory cough monitoring system that was designed to be non-invasive, usable for children and adults of all ages, inexpensive, and highly accurate for the detection of cough with easy to use software for data analysis. Upon its completion, we aimed to pilot its ability to accurately record cough frequency and validate its accuracy in quantitating cough by comparing the auditory recordings of the device with simultaneously performed video recordings serving as the gold-standard.

Materials and methods
=====================

Cough monitor
-------------

The self-contained monitor consists of several components: 1) an accelerometer, 2) an electronic package (dimensions 11.4 cm × 6.7 cm × 2.2 cm, weight 171 grams), 3) a cable connecting the accelerometer to the electronic package, and 4) a CompactFlash memory card. The accelerometer chosen was the BU-1771 (Figure [1a](#F1){ref-type="fig"}; Knowles Electronics Co., Itasca, Illinois, USA), and it is attached to the skin at each subject\'s suprasternal notch as has been done previously using a bioclusive transparent dressing \[[@B13]\]. The accelerometer measures vibration at this location, and transmits output data through a cable to an electronic package (Figure [1b](#F1){ref-type="fig"}) that is typically worn on the belt or in a pocket. There the signal is amplified and a microprocessor performs an analog to digital conversion before storing the data on the CompactFlash memory card (Lexar Media, Inc., Freemont, CA, USA). The monitor is capable of storing 24 hours of data on a 1 GB CompactFlash Card, and is powered by a 9 V battery that is contained within the electronic package.

![The cough monitoring system: a) accelerometer and b) electronic package.](1745-9974-2-7-1){#F1}

Attachment at the suprasternal notch is advantageous for numerous reasons. First, because it is below the larynx, any speech that causes vibrations is unintelligible on the audio recording. This maintains the privacy for the subject that may be recorded for extended periods in an ambulatory setting. Next, it eliminates any interference from swallowing. Third, it is a relatively comfortable location that does not interfere with typical daily activities. Lastly, this location and its method of placement eliminate the problem of movement artifact or distance from an externally located microphone.

Software
--------

The analysis software presents the stored data from the CompactFlash card in a user-friendly manner that allows the user to verify whether a recorded signal represents a cough or not. Importantly, the software can run the stored recording continuously or eliminate silent periods where no signal occurs. The latter feature greatly reduces the time required for analysis. Using a program developed through Matlab^®^(The MathWorks, Natick, MA, USA), a graphical user interface (GUI) enables the user to analyze the cough recordings (Figure [2](#F2){ref-type="fig"}). The user determines whether a signal is a cough or not based on its visual features in time and frequency domains including the visualized slope and typical pattern as described previously \[[@B14]\] as well as its sound, which is played from a \'.wav\' audio file. The combination of visual and audio features allows for easy distinction between other noises such as speech, laughter, or throat clearing. Also, for each cough detected, the intensity of the cough is also calculated. Finally, the GUI generates a post-analysis plot of the data for a summary of the recording (Figure [3](#F3){ref-type="fig"}).

![Data analysis software: Graphical user interface (GUI).](1745-9974-2-7-2){#F2}

![Data analysis software: Post-analysis data summary plot.](1745-9974-2-7-3){#F3}

Participants and recordings
---------------------------

15 subjects with very frequent coughing when evaluated subjectively, or their legal guardians, consented to be recorded with the cough monitor and simultaneous video recording for a period ranging from 15 to 60 minutes. Though the monitor can we worn for much longer periods of time, given the time consuming nature of reviewing longer period of video recording, short periods were selected for this study. Subjects were recorded in the outpatient clinic, hospital, and home environments between November 2004 and February 2005. Subjects were recorded in the home, outpatient, inpatient, and outdoor settings. The Human Subjects Protection Office of the Penn State College of Medicine approved the study.

Cough definitions and recording analysis
----------------------------------------

As has been done previously, a \"cough bout\" was defined as a one-second period of time where the subject was coughing \[[@B13],[@B15]\]. During each cough bout, one or more \"cough components\" could occur. A cough component was defined as individual bursts of air that the patient emits during a cough. Each cough component begins with the first audible phase of a cough.

In this study, only the cough components were analyzed and each component will be referred to as a \"cough\" for the remainder of this manuscript. Two investigators independently analyzed the recordings and counted the number of coughs during the study period from both the cough monitor and the video recording. The two investigators were in the same room at the time of the recording analyses, but were blinded to each other\'s interpretation. Interpretation of what constituted a cough on the video recordings remained subject to investigator discretion. One investigator had no prior experience in cough research, but the second investigator had prior experience with objective cough recordings.

Statistical analysis for validation
-----------------------------------

Using the video recordings as a gold-standard,\[[@B16]\] a sample size calculation indicated that with a total of 23 subjects, a one-sided 95% confidence interval for the concordance correlation coefficient would have a lower limit of 0.90, assuming the true concordance correlation coefficient was 0.95 with variance 1.00. An interim analysis was planned to determine if the sample size required expansion or reduction because the number of coughs per recording was difficult to predict a priori. The concordance correlation coefficient is a reproducibility index that captures precision and accuracy \[[@B17]\]. Any value larger than 0 indicates agreement with 1 indicating perfect agreement. We established a priori that an acceptable level of agreement, as measured by the concordance correlation coefficient, is 0.90. Several parameters were compared in this analysis, including agreement between video counts and audio counts, agreement of audio counts between investigators, and agreement of video counts between investigators. The null hypothesis is the level of agreement is less than or equal to 0.90. Our hypothesis was that level of agreement would be greater than 0.90. We conducted a one-sided hypothesis test at the 0.05 level of significance as well as computed a 95% lower confidence bound. If the *p*-value was below 0.05, we would reject the null hypothesis and conclude we had adequate agreement. Similarly, if the lower confidence bound lay above 0.90, we would conclude that we had adequate agreement.

Results
=======

15 subjects aged 2 weeks to 84 years with cough were enrolled and completed the study (Table [1](#T1){ref-type="table"}). A variety of diagnoses was identified as the cause of each subject\'s cough. Though the recordings ranged between 15 and 60 minutes, all subjects demonstrated relatively frequent coughing during the study periods that allowed for a comparison of cough counts by video and monitor recordings between methods and between investigators.

###### 

Patient characteristics and cough recording results (video and monitor) as determined by two investigators

  **Age**   **Diagnosis**                 **Recording Duration**   **Investigator 1**   **Investigator 2**   **Investigator 1**   **Investigator 2**
  --------- ----------------------------- ------------------------ -------------------- -------------------- -------------------- --------------------
  60 yrs    Pneumonia                     30                       43                   41                   50                   51
  20 mos    Bronchiolitis                 60                       53                   50                   43                   40
  2 yrs     Asthma/pneumonia              30                       45                   45                   48                   47
  55 yrs    COPD                          30                       40                   42                   34                   37
  13 yrs    Pneumonia                     30                       37                   36                   39                   39
  2 wks     Pertussis                     30                       62                   63                   63                   63
  23 yrs    Allergic Rhinitis             30                       29                   32                   28                   29
  6 yrs     Upper Respiratory infection   15                       74                   73                   74                   74
  43 yrs    Upper respiratory infection   15                       80                   81                   81                   82
  45 yrs    Upper respiratory infection   30                       14                   14                   16                   16
  79 yrs    Pneumonia                     30                       17                   19                   15                   15
  16 yrs    Upper respiratory infection   20                       49                   49                   40                   40
  49 yrs    Asthma                        30                       14                   13                   14                   17
  7 yrs     Upper respiratory infection   30                       30                   28                   25                   25
  28 yrs    Upper respiratory infection   30                       69                   68                   64                   64

When measuring agreement between the two investigators, the sample concordance correlation coefficient for audio counts from the new device was 0.998 with a 95% lower confidence bound of 0.994 (*p*\< 0.001). In the comparison of video counts, the sample concordance correlation coefficient was 0.997 with 95% lower confidence bound of 0.991 (*p*\< 0.001). There was good agreement between the two investigators\' audio counts. There was also good agreement between the two investigators\' video counts, and experience with objective cough recordings did not impact the findings.

Next, the agreement between video counts and audio counts were calculated for both investigators. For the comparison of investigator 1\'s video counts to the corresponding audio counts, the sample concordance correlation coefficient was 0.968 with a 95% lower confidence bound of 0.918 (*p*= 0.026). For the comparison of investigator 2\'s video counts to the corresponding counts, the sample concordance correlation coefficient was 0.973 with a 95% lower confidence bound of 0.930 (*p*= 0.015). The agreement level was slightly higher for the more experienced counter; however, this difference was not statistically significant (*p*= 0.990).

Discussion
==========

To overcome the deficiencies of subjective reporting of cough, numerous attempts have been made to develop objective cough monitoring devices. Methods have ranged from very simple devices consisting of a tape recorder placed in a room with a patient to complex devices capable of measuring multiple physiologic parameters including cough \[[@B6],[@B13]-[@B15],[@B18]-[@B29]\]. Most if not all of these systems have some limitation that makes them difficult to use in a subject\'s natural environment with a routine level of activity or does not protect the privacy of their vocal conversations during the recording period.

The results of this study describe a newly developed method of objectively recording and analyzing cough. Though the recordings were for a short durations, the method appears valid and reproducible. Though these findings are limited by the fact that we did not match each video recorded cough to the device recorded cough, the device we describe combines several patient-friendly features since it is a non-invasive, self-contained, and ambulatory device. This distinguishes it from other devices since it does not appear to interfere in any way with routine, daily activities. We also have demonstrated its potential utility in subjects that are very young as well as those that are senior citizens with a variety of medical diagnoses serving as the etiology of their coughing. The software that accompanies the device is user-friendly and produces easily understandable analyses.

Because subjective reporting of cough has been shown to be unreliable, clinical trials that assess the common symptom of cough should consider objective assessments. The device we describe here can also be used in the clinical setting to evaluate the frequency of a patient\'s cough. With further work and the help of acoustics experts, the visual and audio analysis components could be explored as a diagnostic tool to determine the etiology of a cough. It also could potentially be adapted to evaluate other pulmonary sounds such as snoring, stridor, or wheezing.
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